Symptoms persisting after hospitalisation for COVID-19: 12 months interim results of the CO-FLOW study.

L Martine BekJulia C BerentschotMajanka H Heijenbrok-Kal Susanne Huijts Michel E Van GenderenJ Hans VlakeRita J G van den Berg-Emons Joachim G J V Aerts Gerard Maria Ribbers Rita J G van den Berg-Emons Merel Elise Hellemons

Published in: ERJ open research (2022)

The majority of patients experienced COVID-19 sequelae up to 12 months after severe infection. Whereas physical and respiratory symptoms showed slow gradual decline, fatigue and cognitive symptoms did not evidently resolve over time.

Keyphrases

coronavirus disease
sars cov
sleep quality
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
mental health
respiratory syndrome coronavirus
patient reported